BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 12, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 9, 2013
View Archived Issues
Report from Europe: Retina Implant gets CE mark for Alpha IMS RP technology
Read More
Washington roundup: More ACA mandates fall as insurance exchanges roll out
Read More
Deals roundup: ArthroCare completes $45M acquisition of ENTrigue Surgical
Read More
Agreements/contracts: Luna reports multi-year agreement with Intuitive
Read More
Financings roundup: HeadSense secures financing for ICP neurological monitor
Read More
Med-Tech Notes
Read More
People in the News
Read More
Product Briefs
Read More
MDD's Cardio Extra
Read More
Penumbra launches 5MAX ACE blood clot removal application
Penumbra (Alameda, California) reported the launch and wide availability of the 5MAX ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke.
Read More
Report from Israel: Personalized medicine: A perfect storm in the making?
Read More
